CrossrefInfokarte
Comparative safety and efficacy of BIC/FTC/TAF versus DTG+3TC in antiretroviral treatment-naive patients with HIV as first-line regimens: A real-world cohort study
BioScience Trends · 2026-04-30 · 20 (2) · 205-216
DOI: 10.5582/bst.2025.01335 ↗Abstract
Kein Abstract verfügbar.
EUVIMED